(Q40514407)

21 September 2017

title

Nuclear labelling of leukaemic blast cells with tritiated thymidine triphosphate after daunomycin (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

12 June 2022

1 reference

G. L. Wantzin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A271609

12 June 2022

S. A. Killmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A271609

12 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=271609

12 June 2022

publication date

1 July 1977

1 reference

full work available at URL

21 September 2017

https://api.elsevier.com/content/article/PII:0014296477900500?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

https://api.elsevier.com/content/article/PII:0014296477900500?httpAccept=text/plain

12 June 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

European Journal of Cancer

12 June 2022

published in

1 reference

21 September 2017

volume

13

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

647-655

1 reference

Daunorubicin in the treatment of acute myelocytic leukaemia

21 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Daunorubicin in the therapy of acute granulocytic leukemia

12 June 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Inhibition of nucleic acid synthesis by daunomycin and its relationship to the uptake of the drug in HeLa cells

12 June 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

The effect of daunomycin on human cells in vivo and in vitro

12 June 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis

12 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS

12 June 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Stereochemistry of Intercalation: Interaction of Daunomycin with DNA

12 June 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Perturbation of Generation Cycle of Human Leukaemic Blast Cells in vivo by Daunomycin

12 June 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Mode of action of chemotherapy in vivo on human acute leukemia. I. Daunomycin

12 June 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

The effect of daunomycin on cell proliferation and protein synthesis of human leukemic blast cells

12 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Detection of DNA polymerase activity in fixed cells

12 June 2022

15

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Radiation stimulated incorporation of thymidine into the DNA of human lymphocytes

12 June 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Cytophotometric studies of the DNA, nucleic acid and protein content of human liver cell nuclei

12 June 2022

24

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

DNA Synthesis in Normal and Leucemie Cells as Related to Therapy with Cytotoxic Drugs

12 June 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

Adriamycin and Daunorubicin Inhibition of Mutant T4 DNA Polymerases

12 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90050-0

12 February 2023

Identifiers

1 reference

21 September 2017

1 reference